title: Treatment Patterns and Health Outcomes Among Patients with Radioiodine-Refractory Differentiated Thyroid Cancer in the United States and Western Europe.
authors.affiliation: University of California, Los Angeles, Torrance, CA, USA.
authors.forename: A G
authors.initials: AG
authors.lastname: Gianoukakis
authors.affiliation: Kantar Health, New York, NY, USA.
authors.forename: N M
authors.initials: NM
authors.lastname: Flores
authors.affiliation: Eisai Inc, Woodcliff Lake, NJ, USA.
authors.forename: C L
authors.initials: CL
authors.lastname: Pelletier
authors.affiliation: Kantar Health, New York, NY, USA.
authors.forename: M
authors.initials: M
authors.lastname: DiBonaventura
authors.affiliation: Eisai Inc, Woodcliff Lake, NJ, USA.
authors.forename: A
authors.initials: A
authors.lastname: Forsythe
authors.affiliation: Kantar Health, New York, NY, USA.
authors.forename: G
authors.initials: G
authors.lastname: Wolfe
authors.affiliation: Eisai Inc, Woodcliff Lake, NJ, USA.
authors.forename: J
authors.initials: J
authors.lastname: Rege
authors.affiliation: Oregon Health & Science University, Division of Hematology & Medical Oncology, Portland, OR, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Taylor